какво е onglyza за?
add on combination therapy onglyza is indicated in adult patients aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control as monotherapy in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance as dual oral therapy in combination with metformin when metformin alone with diet and exercise does not provide adequate glycaemic control in combination with a sulphonylurea when the sulphonylurea alone with diet and exercise does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate in combination with a thiazolidinedione when the thiazolidinedione alone with diet and exercise does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate as triple oral therapy in combination with metformin plus a sulphonylurea when this regimen alone with diet and exercise does not provide adeq